Skip to main content

CORRECTION article

Front. Pharmacol., 04 February 2022
Sec. Ethnopharmacology

Corrigendum: The Therapeutic Principle of Combined Strengthening Qi and Eliminating Pathogens in Treating Middle-Advanced Primary Liver Cancer: A Systematic Review and Meta-Analysis

Yingqi She&#x;Yingqi She1Qinfeng Huang&#x;Qinfeng Huang2Zhen YeZhen Ye1Yu HuYu Hu1Mingquan WuMingquan Wu3Kaihua QinKaihua Qin4Ailing WeiAiling Wei5Xin YangXin Yang1Yuyao LiuYuyao Liu6Cuihan ZhangCuihan Zhang6Qiaobo Ye
Qiaobo Ye1*
  • 1School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
  • 2Department of Oncology, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, China
  • 3Department of Pharmacy, Sichuan Provincial Orthopedic Hospital, Chengdu, China
  • 4Health Preservation and Rehabilitation College, Chengdu University of Traditional Chinese Medicine, Chengdu, China
  • 5Department of Liver Disease, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, China
  • 6Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu, China

A Corrigendum on
The Therapeutic Principle of Combined Strengthening Qi and Eliminating Pathogens in Treating Middle-Advanced Primary Liver Cancer: A Systematic Review and Meta-Analysis

by She, Y., Huang, Q., Ye, Z., Hu, Y., Wu, M., Qin, K., Wei, A., Yang, X., Liu, Y., Zhang, C. and Ye, Q. (2021). Front. Pharmacol. 12:714287. doi: 10.3389/fphar.2021.714287

In the published article, there was an error in affiliation 2. Instead of “Department of Oncology, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Chengdu, China”, it should be “Department of Oncology, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Chinese medicinal formulas, transcatheter arterial chemoembolization, drastic medicinals, therapeutic principle, primary liver cancer, meta-analysis

Citation: She Y, Huang Q, Ye Z, Hu Y, Wu M, Qin K, Wei A, Yang X, Liu Y, Zhang C and Ye Q (2022) Corrigendum: The Therapeutic Principle of Combined Strengthening Qi and Eliminating Pathogens in Treating Middle-Advanced Primary Liver Cancer: A Systematic Review and Meta-Analysis. Front. Pharmacol. 13:846668. doi: 10.3389/fphar.2022.846668

Received: 31 December 2021; Accepted: 18 January 2022;
Published: 04 February 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 She, Huang, Ye, Hu, Wu, Qin, Wei, Yang, Liu, Zhang and Ye. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Qiaobo Ye, yeqiaobo@cdutcm.edu.cn

These authors contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.